• Sabutoclax: From Bcl-2 Binding to Cell Killing

  2026-09-30

  Sabutoclax is a pan-Bcl-2 inhibitor whose broad target profile makes it valuable for studying apoptosis resistance. This article explains how to distinguish true apoptosis induction in cancer cells from growth arrest by integrating target engagement, orthogonal assays, and response kinetics.

• AMD-070 Hydrochloride: CXCR4 Assay Workflows

  2026-09-30

  Build reproducible migration, signaling, and disease-model assays with AMD-070 hydrochloride, a selective CXCR4 antagonist for probing the CXCR4/CXCL12 axis. The workflow connects WM genomics to practical controls while keeping exploratory antiviral applications analytically separate from established hematology evidence.

• Lypressin acetate: Assay Workflows and Optimization

  2026-09-29

  Lypressin acetate supports receptor pharmacology, antidiuretic modeling, vasoconstriction research, and carefully controlled antiviral hypothesis testing. This workflow-focused guide connects its short biological lifetime and multi-receptor activity with practical assay design, controls, and troubleshooting.

• Standardized Whole-Blood Stimulation for Immunometabolism

  2026-09-28

  Zhao and colleagues describe a standardized whole-blood stimulation protocol that combines pathogen-associated immune challenges with pharmacological modulation of cellular metabolism. The workflow links cytokine measurements to metabolic pathway activity, offering a practical platform for cohort studies and mechanistic immunometabolism research while highlighting the need for careful controls and interpretation.

• Sensitive UHPLC–MS/MS for Methylated Purines

  2026-09-28

  Zhang, Zhang, and Wang developed a stable isotope-dilution UHPLC–ESI-MS/MS method for measuring 12 purine ribonucleosides, including 10 methylated species. Ammonium bicarbonate-enhanced ionization, chromatographic separation of isomers, and sample cleanup helped address sensitivity and matrix-interference problems in cellular measurements.

• Steroid-Induced Protoplast Lysis: 1965 Study Insights

  2026-09-27

  Smith and Shay used osmotically fragile Sarcina lutea protoplasts to test whether synthetic antimicrobial steroids could damage cells independently of the cell wall. Their findings—including steroid-associated lysis and its modification by polyamines, ions, and surfactants—support direct membrane effects as a likely contributor, while leaving the precise molecular mechanism unresolved.

• Vasopressin Analogues: Mechanisms and Therapeutic Scope

  2026-09-26

  Glavaš and colleagues review how structural variation in vasopressin analogues can shift receptor activity, stability, and therapeutic use. Their synthesis places lypressin alongside better-characterized analogues while emphasizing that proposed newer applications, including antiviral activity, require stronger experimental validation.

• 5-Methyl-CTP for Reliable mRNA-Based Cell Assays

  2026-09-25

  Learn where 5-Methyl-CTP (SKU B7967) fits in mRNA workflows that feed into cell viability, proliferation, or cytotoxicity studies. This practical guide covers experimental controls, product specifications, handling, interpretation, and vendor selection without confusing an IVT reagent with a direct cell-assay reagent.

• TUNEL Assays in Spinal Cord Repair Research

  2026-09-25

  How translational researchers can use DNA-fragmentation measurements to interpret cell death alongside vascular repair and blood-spinal cord barrier outcomes after injury.

• Novobiocin Sodium: Assays & Workflows

  2026-09-24

  Use Novobiocin Sodium to probe bacterial DNA gyrase and build carefully controlled in vitro workflows that connect viability, proliferation, and DNA-damage readouts. A Toxoplasma gondii study also highlights a promising antiparasitic research direction—while underscoring why host-cell selectivity and mechanism confirmation matter.

• L1023 Anti-Cancer Compound Library Workflows

  2026-09-24

  Use a broad, pathway-diverse compound collection to find cancer-cell phenotypes, then resolve promising hits with targeted signaling and immune-response assays. This workflow connects high-throughput screening with STING biology while keeping library screening distinct from claims that any specific compound activates STING.

• Latrunculin A: From Actin Mechanism to Translation

  2026-09-23

  Actin perturbation can reveal how cellular architecture supports processes as different as migration and viral replication. This article connects Latrunculin A’s mechanism to a recent duck enteritis virus study and offers a practical framework for interpreting cytoskeletal experiments without overextending their translational claims.

• Sumatriptan Succinate Research Workflows

  2026-09-23

  Use Sumatriptan Succinate as a mechanistically defined 5-HT1 receptor agonist for migraine, neurogenic inflammation, and metabolism studies. This workflow emphasizes concentration control, orthogonal readouts, and parallel MAO/CYP testing so receptor biology is not confused with metabolite effects.

• GLP-1 (9-36) Amide in Translational Research

  2026-09-22

  A mechanistic and strategic guide to using GLP-1 (9-36) amide as a glucagon-like peptide-1 receptor antagonist in receptor signaling, metabolic regulation, and type 2 diabetes research. The article connects assay design, antagonist selection, peptide handling, and translational interpretation while distinguishing product-specific evidence from broader GLP-1 receptor biology.

• Pazopanib in ATRX-Deficient Glioma Research

  2026-09-22

  Pazopanib (GW-786034) provides a practical way to interrogate VEGFR, PDGFR, and FGFR signaling in biomarker-aware cancer research. This workflow connects ATRX-deficient glioma vulnerability with reproducible compound handling, combination testing, and translational angiogenesis models.

7975 records 1/532 page Next 12345 下5页 Last page